A population pharmacokinetic model of methotrexate in Korean patients with hematologic malignancy.

Yun Seob JungMijeong SonSang-Guk LeeJune-Won CheongSoo-Jeong KimJi Eun JangChuhl Joo LyuSeung Min HahnJung Woo HanKyung-Soo Park

Published in: British journal of clinical pharmacology (2023)

The population PK model and optimal dosage regimens developed in this study can be used as a basis to achieve precision dosing in Korean patients with hematologic malignancy.

Keyphrases

high dose
low dose